SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-24-007471
Filing Date
2024-01-29
Accepted
2024-01-29 08:12:08
Documents
16
Period of Report
2024-01-25
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm244291d1_8k.htm   iXBRL 8-K 37517
2 EXHIBIT 99-1 tm244291d1_ex99-1.htm EX-99.1 26005
6 GRAPHIC tm244291d1_ex99-1img001.jpg GRAPHIC 6374
  Complete submission text file 0001104659-24-007471.txt   258998

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hook-20240125.xsd EX-101.SCH 3030
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hook-20240125_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hook-20240125_pre.xml EX-101.PRE 22369
17 EXTRACTED XBRL INSTANCE DOCUMENT tm244291d1_8k_htm.xml XML 3760
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 24570251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)